Limited Scope of Approval PT-141 is only FDA-approved for premenopausal women with diagnosed HSDD
It explains that an individual has PCOS if there is the presence of two out of three features: Oligo- or anovulation Oligoovulation is when ovulation occurs irregularly, leading to irregular or infrequent periods, while anovulation is when ovulation does not occur, leading to absent periods
The lower risk of hormonal imbalances and flexible dosing options further enhance its suitability for individuals with varying health goals and lifestyles
Clean the site, pinch a fold of skin, insert the needle at 90 degrees, deliver the dose slowly, count to six before withdrawing, and use a different spot within the same area next week
During the process, influx of glucose ensures sufficient ATP to sustain the stimulatory effect